Search by Drug Name or NDC
NDC 61874-0075-60 Viberzi 75 mg/1 Details
Viberzi 75 mg/1
Viberzi is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is ELUXADOLINE.
MedlinePlus Drug Summary
Eluxadoline is used to treat irritable bowel syndrome with diarrhea (IBS-D; a condition that causes stomach pain, cramping, or loose or watery stools) in adults. Eluxadoline is in a class of medications called mu-opioid receptor agonists. It works by decreasing bowel activity.
Related Packages: 61874-0075-60Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Eluxadoline
Product Information
| NDC | 61874-0075 |
|---|---|
| Product ID | 61874-075_22af8fe9-6dca-4a72-bb3d-941379ab6b21 |
| Associated GPIs | 52558020000330 |
| GCN Sequence Number | 074654 |
| GCN Sequence Number Description | eluxadoline TABLET 75 MG ORAL |
| HIC3 | D6L |
| HIC3 Description | IBS AGENTS,MIXED OPIOID RECEP AGONISTS/ANTAGONISTS |
| GCN | 39354 |
| HICL Sequence Number | 042445 |
| HICL Sequence Number Description | ELUXADOLINE |
| Brand/Generic | Brand |
| Proprietary Name | Viberzi |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Eluxadoline |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 75 |
| Active Ingredient Units | mg/1 |
| Substance Name | ELUXADOLINE |
| Labeler Name | Allergan, Inc. |
| Pharmaceutical Class | Opioid mu-Receptor Agonists [MoA], mu-Opioid Receptor Agonist [EPC] |
| DEA Schedule | CIV |
| Marketing Category | NDA |
| Application Number | NDA206940 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61874-0075-60 (61874007560)
| NDC Package Code | 61874-075-60 |
|---|---|
| Billing NDC | 61874007560 |
| Package | 60 CARTON in 1 BOTTLE (61874-075-60) / 1 BLISTER PACK in 1 CARTON (61874-075-08) / 8 TABLET, FILM COATED in 1 BLISTER PACK |
| Marketing Start Date | 2015-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 25.5818 |
| Pricing Unit | EA |
| Effective Date | 2024-01-02 |
| NDC Description | VIBERZI 75 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis